News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Elvina Almuradova: Pertuzumab + trastuzumab retreatment to prolong OS in HER2+ metastatic breast cancer
Elvina Almuradova/LinkedIn
Jan 31, 2025, 07:20

Elvina Almuradova: Pertuzumab + trastuzumab retreatment to prolong OS in HER2+ metastatic breast cancer

Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on X:

“PRECIOUS study:

Pertuzumab + trastuzumab retreatment

prolonged OS in HER2+ metastatic breast cancer!  

OS: 36.2 months (PTC) vs. 26.5 months (TC)

PFS: investigator-assessed): 5.5 months (PTC) vs. 4.2 months (TC).”

Elvina Almuradova: Pertuzumab + trastuzumab retreatment to prolong OS in HER2+ metastatic breast cancer

cancer Elvina Almuradova OncoDaily Oncology
Special Coverage
Insight
Jan 31, 2025, 08:42
Commemorating the 1-year anniversary of the partnership with Siemens Healthineers - City Cancer Challenge
Blog
Jan 31, 2025, 08:38
Meet the speakers of the 9th Annual Conference of ELLOK - Zenia Saridaki
Blog
Jan 31, 2025, 07:57
Applications are still open for the M2ICOS project - European School of Oncology
Blog
Jan 31, 2025, 07:35
Dasatinib could be repurposed to treat pediatric ependymoma - NFCR
Blog
Jan 31, 2025, 07:32
SIOG - Can Remote Patient Monitoring improve Cancer Care for older adults?
Blog
Jan 31, 2025, 07:27
Paolo Tarantino: Outcomes and Treatment Patterns for Stage I HER2-Positive Breast Cancer
Blog
Jan 31, 2025, 07:23
Giuseppe Curigliano: Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer
Blog
Jan 31, 2025, 07:21
Shahrin Ahmed: The key solutions for increasing life-saving cervical cancer screenings
Blog
Jan 31, 2025, 07:20
Elvina Almuradova: Pertuzumab + trastuzumab retreatment to prolong OS in HER2+ metastatic breast cancer
Blog
Jan 31, 2025, 07:17
Catherine Alix-Panabières: Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
Blog
Jan 31, 2025, 07:14
Emily Drake: Thrilled to be in Toronto at The Hospital for Sick Children for the ACCESS annual meeting
Blog
Jan 31, 2025, 07:12
Julie S. Torode: Celebrating the Winners of the APCA\TCT 2024 Photography Competition